HK1089946A1 - Non-pegylated long-circulating liposomes - Google Patents

Non-pegylated long-circulating liposomes

Info

Publication number
HK1089946A1
HK1089946A1 HK06110458.8A HK06110458A HK1089946A1 HK 1089946 A1 HK1089946 A1 HK 1089946A1 HK 06110458 A HK06110458 A HK 06110458A HK 1089946 A1 HK1089946 A1 HK 1089946A1
Authority
HK
Hong Kong
Prior art keywords
liposomes
phospholipid
sucrose
ammonium sulphate
hydration
Prior art date
Application number
HK06110458.8A
Other languages
English (en)
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Original Assignee
Bsv Res And Dev Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bsv Res And Dev Private Ltd filed Critical Bsv Res And Dev Private Ltd
Publication of HK1089946A1 publication Critical patent/HK1089946A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06110458.8A 2002-12-31 2006-09-20 Non-pegylated long-circulating liposomes HK1089946A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1101MU2002 2002-12-31
PCT/IN2003/000424 WO2004058140A2 (en) 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes

Publications (1)

Publication Number Publication Date
HK1089946A1 true HK1089946A1 (en) 2006-12-15

Family

ID=32500467

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110458.8A HK1089946A1 (en) 2002-12-31 2006-09-20 Non-pegylated long-circulating liposomes

Country Status (19)

Country Link
EP (1) EP1435231B8 (de)
JP (1) JP5355842B2 (de)
KR (2) KR101171045B1 (de)
CN (1) CN1756533B (de)
AT (1) ATE453381T1 (de)
AU (1) AU2003303368B2 (de)
BR (1) BR0317882A (de)
CA (1) CA2511464C (de)
DE (1) DE60330745D1 (de)
DK (1) DK1435231T3 (de)
EA (1) EA008930B1 (de)
ES (1) ES2337563T3 (de)
HK (1) HK1089946A1 (de)
IL (1) IL169364A (de)
MX (1) MXPA05007102A (de)
NZ (1) NZ540778A (de)
PT (1) PT1435231E (de)
WO (1) WO2004058140A2 (de)
ZA (1) ZA200504850B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811248A2 (pt) 2007-05-16 2014-11-04 Ktb Tumorforschungs Gmbh Formulação de antraciclina de baixa viscosidade.
PT2415470T (pt) * 2009-03-30 2016-08-31 Eisai R&D Man Co Ltd Composição de lipossomas
JP5622719B2 (ja) 2009-03-30 2014-11-12 エーザイ・アール・アンド・ディー・マネジメント株式会社 リポソーム組成物の製造方法
EP2680820B1 (de) * 2011-03-01 2022-11-02 2-BBB Medicines B.V. Fortschrittliches, aktives liposomales laden von schwer wasserlöslichen substanzen
JP6789960B2 (ja) * 2014-11-25 2020-11-25 キュラディグム・エスアエスＣｕｒａｄｉｇｍ Ｓａｓ 医薬組成物、その調製及び使用
JP7015237B2 (ja) 2016-04-28 2022-02-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍の成長を抑制する方法
WO2018064092A1 (en) * 2016-09-27 2018-04-05 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna-damaging agents and dna-pk inhibitors
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN116570775B (zh) * 2023-05-16 2024-08-02 万瑞飞鸿(北京)医疗器材有限公司 一种药物涂层、血管支架及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
WO1985000968A1 (en) * 1983-09-06 1985-03-14 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
CA2263455C (en) * 1996-08-23 2002-10-29 Sequus Pharmaceuticals, Inc. Liposomes containing a cisplatin compound
ATE238039T1 (de) * 1998-09-16 2003-05-15 Alza Corp In liposomen eingeschlossene topoisomerase inhibitoren
KR20000061075A (ko) * 1999-03-23 2000-10-16 린 중친 리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes

Also Published As

Publication number Publication date
WO2004058140A3 (en) 2004-10-28
ES2337563T3 (es) 2010-04-27
JP5355842B2 (ja) 2013-11-27
EP1435231A1 (de) 2004-07-07
IL169364A0 (en) 2007-07-04
WO2004058140B1 (en) 2004-12-16
AU2003303368A1 (en) 2004-07-22
ATE453381T1 (de) 2010-01-15
KR101171045B1 (ko) 2012-08-03
EA200500850A1 (ru) 2006-02-24
CN1756533B (zh) 2010-06-16
ZA200504850B (en) 2006-08-30
EA008930B1 (ru) 2007-08-31
AU2003303368B2 (en) 2010-06-17
PT1435231E (pt) 2010-04-08
CA2511464C (en) 2011-08-23
NZ540778A (en) 2008-04-30
KR20050088233A (ko) 2005-09-02
CA2511464A1 (en) 2004-07-15
DK1435231T3 (da) 2010-04-26
CN1756533A (zh) 2006-04-05
DE60330745D1 (de) 2010-02-11
BR0317882A (pt) 2005-12-13
MXPA05007102A (es) 2005-08-26
EP1435231B1 (de) 2009-12-30
KR101133084B1 (ko) 2012-04-04
KR20110075051A (ko) 2011-07-05
IL169364A (en) 2012-05-31
WO2004058140A2 (en) 2004-07-15
JP2006513189A (ja) 2006-04-20
EP1435231B8 (de) 2010-03-03

Similar Documents

Publication Publication Date Title
HK1089946A1 (en) Non-pegylated long-circulating liposomes
MY143051A (en) Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
HK1062140A1 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical 4-n-(1,2-2-?)
IL151657A0 (en) Methods and kits for locally administering an active agent to an interstitial space of a host
EA200300457A1 (ru) Кристаллический моногидрат, способ его получения и его применение для получения лекарственного средства
CA2250219A1 (en) Materials and methods for making improved liposome compositions
AR002262A1 (es) Composicion y metodo para el tratamiento de enfermedades fungales de las unas y un vendaje adaptado para la administracion topica de medicacion a lasunas.
WO2004110346A3 (en) Sustained release of antiinfectives
ITMI991884A0 (it) Composizioni per la cura della pelle e loro impiego nel curare una pel le danneggiata
BR0117106A (pt) Compostos de lipossoma de microesfera de gás
WO2007003948A3 (en) Core 2 glcnac-t inhibitors
IT8812585A0 (it) Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
NO180147C (no) Fremgangsmåte for fremstilling av HDLC eller et liposom innbefattende et polyen-antisopp-antibiotikum og et lipid
AU2469101A (en) Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles
RU2210573C2 (ru) Углеводные производные
LV5765B4 (lv) (S)-(-)-1-propil-2',6'-pipekoloksilidida hidrohlorida monohidrats ta iegusanas metode un to satuross farmaceitisks preparats
WO2003059246A3 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
BR9606528A (pt) Composto sal de um composto processo para a preparação de um composto composição farmacêutica produto uso de um composto e método para o tratmento de um mamífero que necessita de um agente antineoplásico
CO4960654A1 (es) Metodo para el tratamiento de enfermedades fisiologicas relacionadas con el uso o con las secuelas provocadas por el uso de la cocaina u otros estimulantes psicomotores
NZ516765A (en) Topical formulations comprising skin penetration agents and the use thereof
CA2241825A1 (en) New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
EP1301203A4 (de) Impfstoff beinhaltend azyl-glyceryl phosphatidylinositol manno-oligosaccharide als aktive substanz
PL335016A1 (en) Novel polymorph of 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl]-1-phtalazine acetic acid monohydrate, method of obtaining same, method of obtaining anhydrous 3,4-dihydro-4-oxo-3-[(5-trifluoromethyl)-2-benzoylthiazolyl)methyl-1-phtalazine acetic acid, therapeutic methods, pharmaceutic agent, application of said polymorph in production of such pharmaceutic agent and method of obtaining the last mentioned one
ES2036661T3 (es) Un metodo para preparar una preparacion farmaceutica de pie de atleta.
WO2003000232A3 (en) Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151231